EMCURE share price rises 8.4% after Q2 FY27 results
Key Highlights
Emcure Pharmaceuticals Ltd. (EMCURE) share price rose 8.41% to ₹2,142.90 at 09:34 IST on 4 November 2026 with a net profit of ₹325 crore.
- EMCURE rose 8.41% to ₹2,142.90 at 09:34 IST on 4 Nov 2026.
- so far was 3.42× its 20-session average.
- Q2 FY27 net profit: ₹325 crore, +29.32% on a year earlier.
Figures as of: 09:34 IST, Wednesday 4 November 2026
Emcure Pharmaceuticals Ltd. (EMCURE) share price rose 8.41% to ₹2,142.90 at 09:34 IST on Wednesday 4 November 2026. The trading volume reached 3.42× the 20-session average. The company filed Q2 FY27 results on 3 November 2026, and the share price rose on 4 November 2026. The reported net profit for the quarter was ₹325 crore.
EMCURE share price today
| Price (09:34 IST) | ₹2,142.90 |
| Change from the previous close (₹1,976.60) | +₹166.30 (+8.41%) |
| Day’s range | ₹2,035.10 – ₹2,174.20 |
| Volume so far | 5.0 lakh shares |
| 20-session average daily volume | 1.5 lakh shares (volume so far is 3.42× that) |
| Closing prices of the previous 4 sessions | ₹1,865.00 – ₹1,976.60 |
| 52-week range (adjusted prices) | ₹1,306.50 – ₹2,100.70 |
| Market value at this price | ₹40,653 crore |
The stock traded between ₹2,035.10 and ₹2,174.20 during the session. Trading volume reached 5.0 lakh shares, which is 3.42× the 20-session average. The current price of ₹2,142.90 is 64.0% above the 52-week low of ₹1,306.50.
What has been announced
| When (IST) | Filing |
|---|---|
| Tue 3 Nov, 2:04 pm | Announcement under Regulation 30 (LODR)-Investor Presentation |
| Tue 3 Nov, 1:54 pm | Approval Of Unaudited Financial Results |
| Tue 3 Nov, 1:41 pm | Board Meeting Outcome for Outcome Of Board Meeting Held On November 03 2026 |
Q2 FY27 results at a glance
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Q1 FY27 | Change |
|---|---|---|---|---|---|
| from operations | 2,820 | 2,270 | +24.26% | 2,580 | +9.30% |
| 446 | 341 | +30.59% | 394 | +13.30% | |
| Net profit | 325 | 251 | +29.32% | 292 | +11.14% |
| Net profit as a share of revenue | 11.53% | 11.07% | – | 11.33% | – |
Emcure Pharmaceuticals Ltd. (EMCURE) reported Q2 FY27 revenue from operations of ₹2,820 crore. The net profit was ₹325 crore, which is 29.32% higher than a year earlier. The profit before tax for the quarter was ₹446 crore.
How EMCURE compares with its sector
| Change today | |
|---|---|
| EMCURE | +8.41% |
| +0.50% |
The Pharmaceuticals & Drugs sector stock gained 8.41% while the Nifty 50 index rose 0.50%. Emcure Pharmaceuticals Ltd. (EMCURE) reached a market value of ₹40,653 crore. The share price is currently trading at ₹2,142.90.
EMCURE share price: FAQs
What is the EMCURE share price today?
₹2,142.90 at 09:34 IST on Wednesday 4 November 2026, up ₹166.30 or 8.41% from the previous close of ₹1,976.60.
What were EMCURE’s Q2 FY27 results?
revenue from operations of ₹2,820 crore (+24.26% year on year) and net profit of ₹325 crore (+29.32%), for the quarter ended 30 September 2026.
When did EMCURE announce the results?
The board meeting outcome was filed on Tue 3 Nov, 1:54 pm IST.
This article is for information only and is not investment advice. Prices are from the National Stock Exchange, filings from BSE announcements and results from the company’s reported figures. Calculations are by ThePip. Prices and figures move through the session; the time above says when these were read. Investments in securities are subject to market risks.